-
Juno Therapeutics Inc (NASDAQ: JUNO) shares
reached a new 52-week low of $20.45 as the company disclosed that it has placed JCAR015 Phase II ROCKET trial on clinical hold
after 2 patients suffered cerebral edema earlier this week.
-
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares fell 5.9 percent to touch a new 52-week low of $1.60. BioDelivery
Sciences shares have dropped 72.13 percent over the past 52 weeks, while the S&P 500 index has increased 5.58 percent in
the same period.
-
Eli Lilly and Co (NYSE: LLY) shares reached a new
52-week low of $66.61 after the company’s drug solanezumab failed to meet primary endpoint for the treatment of mild dementia
due to Alzheimer's disease in a late-stage study.
-
AstraZeneca plc (ADR) (NYSE: AZN) shares touched a
new 52-week low of $26.075. AstraZeneca shares have dropped 22.17 percent over the past 52 weeks, while the S&P 500 index
has gained 5.58 percent in the same period.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.